Results 161 to 170 of about 79,249 (245)

Impact of prior chemotherapy on nanoliposomal irinotecan with fluorouracil and folinic acid for unresectable pancreatic cancer: a retrospective analysis of data from the multicenter NAPOLEON-2 study. [PDF]

Ther Adv Med Oncol
Koike T, Kawaguchi Y, Shimokawa M, Otsuka T, Furukawa K, Shinohara Y, Shimokawa H, Yoshihiro T, Shibuki T, Nakazawa J, Arima S, Miwa K, Koga F, Ueda Y, Kubotsu Y, Takeshita S, Nishikawa K, Komori A, Otsu S, Hosokawa A, Sakai T, Oda H, Kawahira M, Arita S, Honda T, Taguchi H, Tsuneyoshi K, Fujita T, Sakae T, Shirakawa T, Mizuta T, Mitsugi K.   +31 more
europepmc   +1 more source

NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancer. [PDF]

Oncologist
Wheless MC, Stockton S, Soares HP, Dayyani F, Saeed A, Kim E, Jin N, Yacoub G, Florou V, Ayers GD, Guerrouahen BS, Contreras A, Li L, Ferry-Galow KV, Gore S, Das S, Berlin J.   +16 more
europepmc   +1 more source

Oxaliplatin versus irinotecan as first-line therapy in metastatic colorectal cancer with prior adjuvant treatment: a retrospective study on efficacy, sequential therapy, and the impact of thrombocytopenia. [PDF]

Front Oncol
Shan H, Huang S, Zhou C, Wang M, Du Q.
europepmc   +1 more source

Real-world efficacy of nanoliposomal irinotecan in patients with advanced pancreatic cancer. [PDF]

BMC Cancer
Decraecker M, Le Joncour S, Aurillac V, Sangnier M, Ducerf C, Berroneau A, Rouleau L, Tougeron D, Laplace C, Madau M, Dumon C, Perrier H, Blanc JF.   +12 more
europepmc   +1 more source

Cost-effectiveness analysis of irinotecan hydrochloride liposome in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma. [PDF]

Front Pharmacol
Zhan S, Feng P.
europepmc   +1 more source

Efficacy of the combined use of bevacizumab and irinotecan in a human colorectal cancer xenograft model analysed by SPECT imaging [PDF]

, 2011
Geboes, Karen, Laurent, Stéphanie, Peeters, Marc, Van Damme, Nancy, Van De Wiele, Christophe, VANGESTEL, CHRISTEL   +5 more
core   +1 more source

Characterization of the anticancer effect of mebendazole and its interaction with standard cytotoxic drugs in patient tumor cells <i>ex vivo</i> and in an <i>in vivo</i> mouse model. [PDF]

Oncol Rep
Mansoori S, Blom K, Andersson C, Fryknäs M, Larsson R, Nygren P.   +5 more
europepmc   +1 more source

Comprehensive pharmacovigilance of phytoalkaloid chemotherapeutics: Signal detection and time-to-onset analysis based on FAERS. [PDF]

Medicine (Baltimore)
Song B, Zhang Y, Wang L, Hu J.
europepmc   +1 more source

Current Systemic Treatment Options for Advanced Pancreatic Cancer-An Overview Article. [PDF]

Biomedicines
Domagała-Haduch M, Długaszek A, Gorzelak-Magiera A, Gisterek-Grocholska I.   +3 more
europepmc   +1 more source

Survival Benefit of Temozolomide Plus Irinotecan as Second-Line Therapy in Small Cell Lung Cancer: A Retrospective Single-Center Study. [PDF]

J Clin Med
Acar O, Agaoglu AB, Sahbazlar M, Ekinci F, Erdogan AP.   +4 more
europepmc   +1 more source